CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows provided by operating activities:
Net loss	$ (283,807)	$ (289)	$ (258,720)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	48,643	59,156	70,000
Provision for doubtful accounts	1,707	2,367	4,469
Stock-based compensation	35,357	25,391	28,964
Loss in equity interests, net	78	908	1,081
Impairment of investment & other intangibles	2,070		5,205
Non-cash restructuring charges		5,315	7,505
Deferred income taxes	(43,418)	28,574	(9,814)
Gain on deconsolidation of subsidiaries	(13,647)
Tax benefit from change in uncertain tax positions		(14,355)	(43,193)
Amount reclassified from accumulated other comprehensive income	1,819	(23,109)
Goodwill impairment	325,800		262,650
Excess income tax benefit from equity compensation plans	(199)	(5,907)
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	40,567	8,018	(2,013)
Prepaid and other	(12,508)	14,573	13,332
Deferred revenue	(32,716)	(22,189)	(17,456)
Accounts payable, accrued liabilities and other	13,009	(44,631)	(8,683)
Total adjustments	366,562	34,111	312,047
Net cash provided by operating activities	82,755	33,822	53,327
Cash flows used for investing activities:
Capital expenditures	(39,843)	(32,616)	(59,572)
Payments for acquisitions, net of cash acquired	(27,005)
Investment in Alma Career Oy	(6,516)
Cash funded to and dividends received from equity investee and other	(2,163)	(6,266)	(1,349)
Capitalized patent defense costs	(4,539)
Net cash used for investing activities	(80,066)	(38,882)	(60,921)
Cash flows provided by (used for) financing activities:
Payments on borrowings on credit facilities	(192,300)	(91,599)	(305,709)
Proceeds from borrowings on credit facilities	146,400	69,500	224,718
Payments on borrowings on term loan	(91,625)	(6,875)	(43,750)
Proceeds from borrowings on term loan	90,000		100,000
Proceeds from issuance of convertible notes	143,750
Fees paid on the issuance of debt and purchase of capped call	(23,111)
Repurchase of common stock	(52,070)	(107,167)	(65,611)
Tax withholdings related to net share settlements of restricted stock awards and units	(10,565)	(6,061)	(8,459)
Excess income tax benefit from equity compensation plans	199	5,907
Net proceeds from sale of noncontrolling interest		86,523
Dividend paid to minority shareholder	(3,021)
Net cash provided by (used for) financing activities	7,657	(49,772)	(98,811)
Effects of exchange rates on cash	(4,630)	(4,772)	4,273
Net increase (decrease) in cash and cash equivalents	5,716	(59,604)	(102,132)
Cash and cash equivalents, beginning of period	88,581	148,185	250,317
Cash and cash equivalents, end of period	$ 94,297	$ 88,581	$ 148,185